THERAPEUTIC POTENTIAL OF CHOLECYSTOKININ RECEPTOR ANTAGONISTS IN CNS DISORDERS

被引：10
|
作者：
SCHIANTARELLI, P
机构：
[1] Preclinical Research Division, Boehringer Ingelheim Italy, 20139 Milano
来源：
PHARMACOLOGICAL RESEARCH | 1993年 / 28卷 / 01期
关键词：
D O I：
10.1006/phrs.1993.1104
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 9
页数：9
相关论文
共 50 条
  • [1] Cholecystokinin antagonists: Pharmacological and therapeutic potential
    Herranz, R
    MEDICINAL RESEARCH REVIEWS, 2003, 23 (05) : 559 - 605
  • [2] Cholecystokinin and psychiatric disorders - Role in aetiology and potential of receptor antagonists in therapy
    Shlik, J
    Vasar, E
    Bradwejn, J
    CNS DRUGS, 1997, 8 (02) : 134 - 152
  • [3] Role of cholecystokinin in the development and progression of acute pancreatitis and the potential of therapeutic application of cholecystokinin receptor antagonists
    Niederau, C
    Grendell, JH
    DIGESTION, 1999, 60 : 69 - 74
  • [4] Therapeutic potential for endothelin receptor antagonists in cardiovascular disorders
    Spieker L.E.
    Noll G.
    Lüscher T.F.
    American Journal of Cardiovascular Drugs, 2001, 1 (4) : 293 - 303
  • [5] Neuropeptide receptor antagonists for CNS disorders
    Kehne, JH
    Maynard, GD
    De Lombaert, S
    Krause, JE
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 38, 2003, 38 : 11 - 20
  • [6] A 2ND GENERATION OF NONPEPTIDE CHOLECYSTOKININ RECEPTOR ANTAGONISTS AND THEIR POSSIBLE THERAPEUTIC POTENTIAL
    FREEDMAN, SB
    PATEL, S
    SMITH, AJ
    CHAPMAN, K
    FLETCHER, A
    KEMP, JA
    MARSHALL, GR
    HARGREAVES, RJ
    SCHOLEY, K
    MELLIN, EC
    DIPARDO, RM
    BOCK, MG
    FREIDINGER, RM
    CHOLECYSTOKININ, 1994, 713 : 312 - 318
  • [7] The development of cytokine receptor antagonists as potential therapeutic agents for the myeloproliferative disorders
    Ramshaw, H
    Lopez, A
    Bardy, P
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (05) : 357 - 368
  • [8] Therapeutic potential of agmatine for CNS disorders
    Neis, Vivian B.
    Rosa, Priscila B.
    Olescowicz, Gislaine
    Rodrigues, Ana Lucia S.
    NEUROCHEMISTRY INTERNATIONAL, 2017, 108 : 318 - 331
  • [9] Therapeutic potential of steroids for CNS disorders
    Hamilton, NM
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2001, 11 (10) : 1523 - 1531
  • [10] Selective orexin receptor antagonists for the treatment of CNS disorders
    Shireman, Brock T.
    Letavic, Michael A.
    Bonaventure, Pascal
    Branstetter, Bryan
    Dugovic, Christine
    Hack, Michael
    Lord, Brian
    Ly, Kiev S.
    Morton, Kirsten L.
    Rudolph, Dale A.
    Savall, Brad M.
    Shah, Chandra
    Shelton, Jonathan
    Shoblock, James
    Nepomuceno, Diane
    Lovenberg, Timothy W.
    Carruthers, Nicholas I.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
12345